What are the recommended medications and dosing for managing inpatient alcohol withdrawal?

Inpatient Alcohol Withdrawal Medications

Benzodiazepines are the first-line treatment for inpatient alcohol withdrawal, with long-acting agents (chlordiazepoxide 25-100 mg PO every 4-6 hours or diazepam 5-10 mg PO/IV/IM every 6-8 hours) preferred for most patients, but switch to lorazepam 1-4 mg PO/IV/IM every 4-8 hours for patients with liver failure, advanced age, respiratory failure, or severe comorbidities. 1, 2

Core Pharmacological Approach

Benzodiazepines (Mandatory First-Line)

The evidence unequivocally supports benzodiazepines as the gold standard—they reduce withdrawal severity, prevent seizures (reducing seizures by 7.7 per 100 patients), and prevent delirium tremens (reducing delirium by 4.9 cases per 100 patients) 3. All patients with moderate to severe alcohol withdrawal syndrome require benzodiazepine therapy 1, 2.

Agent selection based on patient characteristics:

• Standard patients without liver disease: Use long-acting benzodiazepines

  • Chlordiazepoxide: 25-100 mg PO every 4-6 hours 1
  • Diazepam: 5-10 mg PO/IV/IM every 6-8 hours 1
  • These provide superior seizure and delirium protection through sustained GABA receptor activation 1

• Patients with liver failure, advanced age, head trauma, respiratory failure, obesity, or multiple comorbidities: Use intermediate-acting benzodiazepines

  • Lorazepam: Start 6-12 mg/day divided (1-4 mg every 4-8 hours), taper after symptom resolution 1
  • Lorazepam avoids accumulation in hepatic dysfunction 2, 4

Dosing strategy: Use symptom-triggered therapy rather than fixed-dose schedules—this reduces total medication administered and shortens treatment duration while maintaining efficacy 2, 3. However, in cirrhotic patients, over 70% may not require benzodiazepines at all, so prescribe only when withdrawal symptoms are present 4.

Thiamine (Mandatory for All Patients)

Give thiamine 100-300 mg/day to ALL patients with alcohol withdrawal 1. This prevents Wernicke encephalopathy, which occurs in 30-80% of alcohol-dependent patients with thiamine deficiency 4.

Critical timing: Administer thiamine BEFORE giving IV fluids containing glucose, as glucose administration can precipitate acute thiamine deficiency 1.

Continue thiamine for 2-3 months after withdrawal symptom resolution 1. If Wernicke encephalopathy develops, increase to 100-500 mg/day for 12-24 weeks 1.

Adjunctive Medications

Carbamazepine

• Dosing: 200 mg PO every 6-8 hours 1
• Role: Alternative to benzodiazepines for seizure prevention 1
• Use when benzodiazepines are contraindicated or as adjunct in refractory cases

Haloperidol

• Dosing: 0.5-5 mg PO every 8-12 hours or 2-5 mg IM 1
• Role: ONLY as adjunctive therapy for agitation or psychotic symptoms (hallucinations) not controlled by benzodiazepines 1
• Critical caveat: Never use as monotherapy—phenothiazines are less effective than benzodiazepines at reducing delirium (P=0.002) and seizures (P<0.001) 3

Emerging Agents for Benzodiazepine-Resistant Withdrawal

For ICU patients with treatment-resistant withdrawal despite escalating benzodiazepine doses:

• Phenobarbital or propofol show efficacy 5, 6
• Dexmedetomidine may reduce intubation need but doesn't address underlying pathophysiology 5

Essential Supportive Care

Beyond medications, provide:

• Fluids and electrolytes (especially magnesium replacement) 1
• Comfortable, calm environment 1
• Frequent vital sign monitoring for autonomic instability (fever, tachycardia, hypertension, sweating) 1
• Evaluate for comorbidities: dehydration, electrolyte imbalance, infection, GI bleeding, pancreatitis, hepatic encephalopathy 1

Common Pitfalls to Avoid

1. Don't use CIWA for diagnosis—it's helpful for severity assessment and treatment planning but can be falsely elevated in anxiety disorders, sepsis, hepatic encephalopathy, and severe pain 1

2. Don't continue benzodiazepines beyond 10-14 days—both benzodiazepines and clomethiazole carry abuse potential, and patients with alcohol use disorder are at higher risk 2

3. Don't use naltrexone, nalmefen, or disulfiram during acute withdrawal—these are contraindicated in hepatic insufficiency and are for maintenance of abstinence, not acute withdrawal management 4

4. Don't forget psychiatric consultation—it's recommended for evaluation, acute management, and long-term abstinence planning 1

Indications for Inpatient Admission

Admit patients with:

• Significant withdrawal symptoms
• History of withdrawal seizures or delirium tremens
• Serious medical or psychiatric comorbidities
• High levels of recent drinking
• Failed outpatient treatment 1